Reimbursement Matters
| Autor: | Simon J. Craddock Lee, Jasmin A. Tiro, John Cox, Ethan A. Halm, Rasmi G Nair, Caitlin C. Murphy, Ann M. Geiger, Celette Sugg Skinner, David E. Gerber |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
Male Research design medicine.medical_specialty Accrual MEDLINE Medical Oncology Article Potential conflict Interviews as Topic 03 medical and health sciences 0302 clinical medicine Neoplasms Physicians medicine Humans 030212 general & internal medicine Reimbursement Clinical Trials as Topic Motivation Descriptive statistics Conflict of Interest business.industry Patient Selection 030503 health policy & services Public Health Environmental and Occupational Health Conflict of interest Middle Aged Clinical trial Cross-Sectional Studies Family medicine Female Patient Participation 0305 other medical science business |
| Zdroj: | Med Care |
| ISSN: | 0025-7079 |
| Popis: | Background Accrual to cancer clinical trials is suboptimal. Few data exist regarding whether financial reimbursement might increase accruals. Objective The objective of this study was to assess perceptions about reimbursement to overcome barriers to trial accrual. Research design This was a cross-sectional survey. Subjects Oncologists identified from the American Medical Association Physician Masterfile. Measures We report descriptive statistics, associations of physician characteristics with perceptions of reimbursement, domains, and subthemes of free-text comments. Results Respondents (n=1030) were mostly medical oncologists (59.4%), ages 35-54 (67%), and male (75%). Overall, 30% reported discussing trials with >25% of patients. Barriers perceived were administrative/regulatory, physician/staff time, and eligibility criteria. National Cancer Institute cooperative group participants and practice owners were more likely to endorse higher reimbursement. Respondents indicated targeted reimbursement would help improve infrastructure, but also noted potential ethical problems with reimbursement for discussion (40.7%) and accrual (85.9%). Free-text comments addressed reimbursement sources, recipients, and concerns about the real and apparent conflict of interest. Conclusions Though concerns about a potential conflict of interest remain paramount and must be addressed in any new system of reimbursement, oncologists believe reimbursement to enhance infrastructure could help overcome barriers to trial accrual. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|